![Wear a mask, get vaccinated and keep your distance' – how to do your bit to help the NHS in Devon this winter - Torbay and South Devon NHS Foundation Trust Wear a mask, get vaccinated and keep your distance' – how to do your bit to help the NHS in Devon this winter - Torbay and South Devon NHS Foundation Trust](https://www.torbayandsouthdevon.nhs.uk/uploads/how-to-do-your-bit-22458.png)
Wear a mask, get vaccinated and keep your distance' – how to do your bit to help the NHS in Devon this winter - Torbay and South Devon NHS Foundation Trust
![Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator - GOV.UK Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator - GOV.UK](https://assets.publishing.service.gov.uk/government/uploads/system/uploads/image_data/file/166637/s960_Gov_UK.jpg)
Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator - GOV.UK
![Vaccines | Free Full-Text | Drivers of the Intention to Receive a COVID-19 Booster Vaccine: Insights from the UK and Australia Vaccines | Free Full-Text | Drivers of the Intention to Receive a COVID-19 Booster Vaccine: Insights from the UK and Australia](https://pub.mdpi-res.com/vaccines/vaccines-10-01730/article_deploy/html/images/vaccines-10-01730-g001.png?1666000989)
Vaccines | Free Full-Text | Drivers of the Intention to Receive a COVID-19 Booster Vaccine: Insights from the UK and Australia
![COVID vaccinations: questions and answers about the rollout in North Yorkshire - NHS North Yorkshire CCG COVID vaccinations: questions and answers about the rollout in North Yorkshire - NHS North Yorkshire CCG](https://northyorkshireccg.nhs.uk/wp-content/uploads/2022/01/Covid-Vaccine-Eligibility-v4-scaled.jpg)
COVID vaccinations: questions and answers about the rollout in North Yorkshire - NHS North Yorkshire CCG
![Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters | The University of Edinburgh Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters | The University of Edinburgh](https://www.ed.ac.uk/sites/default/files/styles/landscape_breakpoints_theme_uoe_mobile_1x/public/thumbnails/image/final_v0.3_vbp_booster_vbs_infographic_3.png?itok=dgJ-Kjqg)
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters | The University of Edinburgh
![Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial - Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -](https://www.thelancet.com/cms/attachment/966d70c5-8395-4ea2-9a35-94dc18f2f550/gr1.gif)
Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -
![Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: An observational study of 22,139 fully vaccinated adults in the UK - The Lancet Regional Health – Europe Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: An observational study of 22,139 fully vaccinated adults in the UK - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/attachment/554ab103-30c1-4227-b822-f7b1c7f002c5/gr1_lrg.jpg)